Improving Early-Stage Diagnosis and Management of COPD in Primary Care

References

• . Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.org/. Accessed February 17, 2014
   Google Scholar
• . Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970–2002. JAMA. 2005;294(10):1255–1259
   PubMed Web of Science ®Google Scholar
• . National Institutes of Health NH, Lung, and Blood Institute. Morbidity and Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases. http://www.nhlbi.nih.gov/resources/docs/2012_ChartBook.pdf. Accessed May 14, 2013
   Google Scholar
• . Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128
   PubMed Web of Science ®Google Scholar
• . World Health Organization. Chronic obstructive pulmonary disease (COPD): Factsheet N^o 315. http://www.who.int/mediacentre/factsheets/fs315/en/. Accessed February 15, 2013
   Google Scholar
• . Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, . Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med. 2011;105(1):57–66
   PubMed Web of Science ®Google Scholar
• . National Heart L, and Blood Institute. Morbidity and Mortality: 2009 Chart Book on Cardiovascular, Lung, and Blood Diseases. http://www.nhlbi.nih.gov/resources/docs/2009_ChartBook.pdf 2009. Accessed May 14, 2013
   Google Scholar
• . American Lung Association. Chronic Obstructive Pulmonary Disease (COPD) Fact Sheet. 2011
   Google Scholar
• . Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, . An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693–718
   PubMed Web of Science ®Google Scholar
• . Joish VN, Brady E, Stockdale W, Brixner DI, Dirani R. Evaluating diagnosis and treatment patterns of COPD in primary care. Treat Respir Med. 2006;5(4):283–293
   PubMedGoogle Scholar
• . Mapel DW, Dalal AA, Blanchette CM, Petersen H, Ferguson GT. Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims. Int J Chron Obstruct Pulmon Dis. 2011;6:573–581
   PubMed Web of Science ®Google Scholar
• . Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008;63(5):402–407
   PubMed Web of Science ®Google Scholar
• . Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009;374(9691):721–732
   PubMed Web of Science ®Google Scholar
• . Radin A, Cote C. Primary care of the patient with chronic obstructive pulmonary disease-part 1: frontline prevention and early diagnosis. Am J Med. 2008;121( 7 Suppl):S3–S12
   PubMed Web of Science ®Google Scholar
• . Tinkelman DG, Price D, Nordyke RJ, Halbert RJ. COPD screening efforts in primary care: what is the yield? Prim Care Respir J. 2007;16(1):41–48
   PubMedGoogle Scholar
• . Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2000;160(11):1683–1689
   PubMed Web of Science ®Google Scholar
• . Yawn BP. Optimizing chronic obstructive pulmonary disease management in primary care. South Med J. 2011;104(2):121–127
   PubMed Web of Science ®Google Scholar
• . Heins-Nesvold J, Carlson A, King-Schultz L, Joslyn KE. Patient identified needs for chronic obstructive pulmonary disease versus billed services for care received. Int J Chron Obstruct Pulmon Dis. 2008;3(3):415–421
   PubMedGoogle Scholar
• . Bellamy D, Smith J. Role of primary care in early diagnosis and effective management of COPD. Int J Clin Pract. 2007;61(8):1380–1389
   PubMed Web of Science ®Google Scholar
• . Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care. 2003;48(12):1204–1213; discussion 1213–1205
   PubMedGoogle Scholar
• . Zoia MC, Corsico AG, Beccaria M, Guarnone R, Cervio G, Testi R, . Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management. Respir Med. 2005;99(12):1568–1575
   PubMed Web of Science ®Google Scholar
• . McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, . Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365(17):1567–1575
   PubMed Web of Science ®Google Scholar
• . Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(6):622–629
   PubMed Web of Science ®Google Scholar
• . Drummond MB, Hansel NN, Connett JE, Scanlon PD, Tashkin DP, Wise RA. Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(12):1301–1306
   PubMed Web of Science ®Google Scholar
• . Bridevaux PO, Gerbase MW, Probst-Hensch NM, Schindler C, Gaspoz JM, Rochat T. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax. 2008;63(9):768–774
   PubMed Web of Science ®Google Scholar
• . Mapel DW, Roberts MH. New clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analyses. Pharmacoeconomics. 2012;30(10):869–885
   PubMed Web of Science ®Google Scholar
• . O'Reilly JF, Williams AE, Holt K, Rice L. Defining COPD exacerbations: impact on estimation of incidence and burden in primary care. Prim Care Respir J. 2006;15(6):346–353
   PubMedGoogle Scholar
• . Thomas M, Decramer M, O'Donnell DE. No room to breathe: the importance of lung hyperinflation in COPD. Prim Care Respir J. 2013;22(1):101–111
   PubMedGoogle Scholar
• . Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, Mannino D, . COPD as a lung disease with systemic consequences—clinical impact, mechanisms, and potential for early intervention. COPD. 2008;5(4):235–256
   PubMedGoogle Scholar
• . O'Donnell DE, Guenette JA, Maltais F, Webb KA. Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise. Chest. 2012;141(3):753–762
   PubMed Web of Science ®Google Scholar
• . Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–946
   PubMed Web of Science ®Google Scholar
• . Qaseem A, Snow V, Shekelle P, Sherif K, Wilt TJ, Weinberger S, . Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007;147(9):633–638
   PubMed Web of Science ®Google Scholar
• . Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%. Chest. 2007;131(2):349–355
   PubMed Web of Science ®Google Scholar
• . Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;148(7):529–534
   PubMed Web of Science ®Google Scholar
• . Thorn J, Tilling B, Lisspers K, Jorgensen L, Stenling A, Stratelis G. Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: a real-life study and cost-effectiveness analysis. Prim Care Respir J. 2012;21(2):159–166
   PubMedGoogle Scholar
• . Halbert RJ, Isonaka S. International Primary Care Respiratory Group (IPCRG) Guidelines: integrating diagnostic guidelines for managing chronic respiratory diseases in primary care. Prim Care Respir J. 2006;15(1):13–19
   PubMedGoogle Scholar
• . van den Boom G, Rutten-van Molken MP, Tirimanna PR, van Schayck CP, Folgering H, van Weel C. Association between health-related quality of life and consultation for respiratory symptoms: results from the DIMCA programme. Eur Respir J. 1998;11(1):67–72
   PubMed Web of Science ®Google Scholar
• . Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, . Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179–191
   PubMed Web of Science ®Google Scholar
• . Salinas GD, Williamson JC, Kalhan R, Thomashow B, Scheckermann JL, Walsh J, . Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians. Int J Chron Obstruct Pulmon Dis. 2011;6:171–179
   PubMed Web of Science ®Google Scholar
• . Yawn BP, Wollan PC. Knowledge and attitudes of family physicians coming to COPD continuing medical education. Int J Chron Obstruct Pulmon Dis. 2008;3(2):311–317
   PubMedGoogle Scholar
• . Foster JA, Yawn BP, Maziar A, Jenkins T, Rennard SI, Casebeer L. Enhancing COPD management in primary care settings. Med Gen Med. 2007;9(3):24
   PubMedGoogle Scholar
• . Duvall K, Frank GW. Identifying chronic obstructive pulmonary disease in primary care of urban underserved patients: tools, applications, and challenges. J Natl Med Assoc. 2010;102(7):570–578
   PubMed Web of Science ®Google Scholar
• . Thun MJ, Carter BD, Feskanich D, Freedman ND, Prentice R, Lopez AD, . 50-year trends in smoking-related mortality in the United States. N Engl J Med. 2013;368(4):351–364
   PubMed Web of Science ®Google Scholar
• . Dransfield MT, Bailey WC. COPD: racial disparities in susceptibility, treatment, and outcomes. Clin Chest Med. 2006;27(3):463–471, vii
   PubMed Web of Science ®Google Scholar
• . Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma. 2006;43(1):75–80
   PubMed Web of Science ®Google Scholar
• . Tashkin DP, Celli B, Decramer M, Liu D, Burkhart D, Cassino C, . Bronchodilator responsiveness in patients with COPD. Eur Respir J. 2008;31(4):742–750
   PubMed Web of Science ®Google Scholar
• . Price DB, Yawn BP, Jones RC. Improving the differential diagnosis of chronic obstructive pulmonary disease in primary care. Mayo Clin Proc. 2010;85(12):1122–1129
   PubMed Web of Science ®Google Scholar
• . Spencer P, Krieger B. The differentiation of chronic obstructive pulmonary disease from asthma: a review of current diagnostic and treatment recommendations. Open Nurs J. 2013;7:29–34
   PubMedGoogle Scholar
• . Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.org/. Accessed February 15, 2013
   Google Scholar
• . Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, . Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167(3):418–424
   PubMed Web of Science ®Google Scholar
• . Moore PL. Practice management and chronic obstructive pulmonary disease in primary care. Am J Med. 2007;120(8 Suppl 1):S23–S27
   PubMed Web of Science ®Google Scholar
• . Han MK, Kim MG, Mardon R, Renner P, Sullivan S, Diette GB, . Spirometry utilization for COPD: how do we measure up? Chest. 2007;132(2):403–409
   PubMed Web of Science ®Google Scholar
• . Joo MJ, Lee TA, Weiss KB. Geographic variation of spirometry use in newly diagnosed COPD. Chest. 2008;134(1):38–45
   PubMed Web of Science ®Google Scholar
• . Lee TA, Bartle B, Weiss KB. Spirometry use in clinical practice following diagnosis of COPD. Chest. 2006;129(6):1509–1515
   PubMed Web of Science ®Google Scholar
• . Price D, Crockett A, Arne M, Garbe B, Jones RC, Kaplan A, . Spirometry in primary care case-identification, diagnosis and management of COPD. Prim Care Respir J. 2009;18(3):216–223
   PubMedGoogle Scholar
• . Enright P. The use and abuse of office spirometry. Prim Care Respir J. 2008;17(4):238–242
   PubMedGoogle Scholar
• . Enright PL. Should we keep pushing for a spirometer in every doctor's office? Respir Care. 2012;57(1):146–151, discussion 151–153
   PubMed Web of Science ®Google Scholar
• . Yawn BP, Enright PL, Lemanske RF, Jr, Israel E, Pace W, Wollan P, . Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD. Chest. 2007;132(4):1162–1168
   PubMed Web of Science ®Google Scholar
• . Enright P, Quanjer P. Spirometry for COPD is both underutilized and overutilized. Chest. 2007;132(2):368–370
   PubMed Web of Science ®Google Scholar
• . Raghavan N, Lam YM, Webb KA, Guenette JA, Amornputtisathaporn N, Raghavan R, . Components of the COPD Assessment Test (CAT) associated with a diagnosis of COPD in a random population sample. COPD. 2012;9(2):175–183
   PubMedGoogle Scholar
• . Calverley PM, Nordyke RJ, Halbert RJ, Isonaka S, Nonikov D. Development of a population-based screening questionnaire for COPD. COPD. 2005;2(2):225–232
   PubMedGoogle Scholar
• . Martinez FJ, Raczek AE, Seifer FD, Conoscenti CS, Curtice TG, D'Eletto T, . Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD. 2008;5(2):85–95
   PubMedGoogle Scholar
• . Mullerova H, Wedzicha J, Soriano JB, Vestbo J. Validation of a chronic obstructive pulmonary disease screening questionnaire for population surveys. Respir Med. 2004;98(1):78–83
   PubMed Web of Science ®Google Scholar
• . Price DB, Tinkelman DG, Halbert RJ, Nordyke RJ, Isonaka S, Nonikov D, . Symptom-based questionnaire for identifying COPD in smokers. Respiration. 2006;73(3):285–295
   PubMed Web of Science ®Google Scholar
• . Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ, Isonaka S, Nonikov D, . Symptom-based questionnaire for differentiating COPD and asthma. Respiration. 2006;73(3):296–305
   PubMed Web of Science ®Google Scholar
• . Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–54
   PubMed Web of Science ®Google Scholar
• . Jing JY, Huang TC, Cui W, Xu F, Shen HH. Should FEV1/FEV6 replace FEV1/FVC ratio to detect airway obstruction? A metaanalysis. Chest. 2009;135(4):991–998
   PubMed Web of Science ®Google Scholar
• . Gil-Guillen V, Orozco-Beltran D, Carratala Munuera CV, Plaza-Sirvent C, Lorca-Amorrich P, Lopez-Pineda A, . FUMEPOC: early detection of chronic obstructive pulmonary disease in smokers. BMC Public Health. 2011;11:413
   PubMed Web of Science ®Google Scholar
• . Yawn BP, Duvall K, Peabody J, Albers F, Iqbal A, Paden H, Zubek VB, Wadland WC. The impact of screening tools on diagnosis of COPD in primary care. Am J Prevent Med. In press
   Google Scholar
• . Albers F, Shaikh A, Iqbal A. Design, rationale, and baseline demographics of SEARCH I: a prospective cluster-randomized study. Int J Chron Obstruct Pulmon Dis. 2012;7:437–445
   PubMed Web of Science ®Google Scholar
• . Nelson SB, LaVange LM, Nie Y, Walsh JW, Enright PL, Martinez FJ, . Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population. Chest. 2012;142(2):358–366
   PubMed Web of Science ®Google Scholar
• . Sichletidis L, Spyratos D, Papaioannou M, Chloros D, Tsiotsios A, Tsagaraki V, . A combination of the IPAG questionnaire and PiKo-6(R) flow meter is a valuable screening tool for COPD in the primary care setting. Prim Care Respir J. 2011;20(2):184–189
   PubMedGoogle Scholar
• . Fuller L, Conrad WF, Heaton PC, Panos R, Eschenbacher W, Frede SM. Pharmacist-managed chronic obstructive pulmonary disease screening in a community setting. J Am Pharm Assoc (2003). 2012;52(5):e59–e66
   PubMed Web of Science ®Google Scholar
• . Jithoo A, Enright PL, Burney P, Buist AS, Bateman ED, Tan WC, . Case-finding options for COPD: Results from the BOLD Study. Eur Respir J. 2013;41(3):548–555
   PubMed Web of Science ®Google Scholar
• . Enright P, White P. Detecting mild COPD: don't waste resources. Prim Care Respir J. 2011;20(1):6–8
   PubMedGoogle Scholar
• . Raghavan N, Guenette JA, O'Donnell DE. The role of pharmacotherapy in mild to moderate chronic obstructive pulmonary disease. Ther Adv Respir Dis. 2011;5(4):245–254
   PubMedGoogle Scholar
• . Maltais F, Dennis N, Chan CK. Rationale for Earlier Treatment in COPD: A systematic review of published literature in mild-to-moderate COPD. COPD. 2013;10(1):79–103
   PubMedGoogle Scholar
• . Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142(4):233–239
   PubMed Web of Science ®Google Scholar
• . Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med. 2002;166(5):675–679
   PubMed Web of Science ®Google Scholar
• . Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000;161(2 Pt 1):381–390
   PubMed Web of Science ®Google Scholar
• . Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, . Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994;272(19):1497–1505
   PubMed Web of Science ®Google Scholar
• . Fiore MC, Baker TB. Clinical practice. Treating smokers in the health care setting. N Engl J Med. 2011;365(13):1222–1231
   PubMed Web of Science ®Google Scholar
• . O'Donnell DE, Hernandez P, Kaplan A, Aaron S, Bourbeau J, Marciniuk D, . Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease—2008 update—highlights for primary care. Can Respir J. 2008;15 Suppl A: 1A–8A
   PubMed Web of Science ®Google Scholar
• . Poole PJ, Chacko E, Wood-Baker RW, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;(1):CD002733
   Google Scholar
• . Cooper CB, Dransfield M. Primary care of the patient with chronic obstructive pulmonary disease-part 4: understanding the clinical manifestations of a progressive disease. Am J Med. 2008;121 ( 7 Suppl):S33–S45
   PubMed Web of Science ®Google Scholar
• . Obert J, Burgel PR. Pneumococcal infections: association with asthma and COPD. Med Mal Infect. 2012;42(5):188–192
   PubMed Web of Science ®Google Scholar
• . Egede LE, Zheng D. Racial/ethnic differences in influenza vaccination coverage in high-risk adults. Am J Public Health. 2003;93(12):2074–2078
   PubMed Web of Science ®Google Scholar
• . Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586
   PubMed Web of Science ®Google Scholar
• . Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, . Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1):29–35
   PubMed Web of Science ®Google Scholar
• . Ferguson GT. Maintenance pharmacotherapy of mild and moderate COPD: what is the evidence? Respir Med. 2011;105(9):1268–1274
   PubMed Web of Science ®Google Scholar
• . Jenkins CR, Jones PW, Calverley PM, Celli B, Anderson JA, Ferguson GT, . Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res. 2009;10:59
   PubMed Web of Science ®Google Scholar
• . Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009;374(9696):1171–1178
   PubMed Web of Science ®Google Scholar
• . Lofdahl CG, Postma DS, Pride NB, Boe J, Thoren A. Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD. Eur Respir J. 2007;29(6):1115–1119
   PubMed Web of Science ®Google Scholar
• . van Grunsven P, Schermer T, Akkermans R, Albers M, van den Boom G, van Schayck O, . Short- and long-term efficacy of fluticasone propionate in subjects with early signs and symptoms of chronic obstructive pulmonary disease. Results of the DIMCA study. Respir Med. 2003;97(12):1303–1312
   PubMed Web of Science ®Google Scholar
• . van Grunsven PM, van Schayck CP, van Deuveren M, van Herwaarden CL, Akkermans RP, van Weel C. Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) Study. J Asthma. 2000;37(3):225–234
   PubMed Web of Science ®Google Scholar
• . Pauwels RA, Lofdahl CG, Laitinen LA, Schouten JP, Postma DS, Pride NB, . Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med. 1999;340(25):1948–1953
   PubMed Web of Science ®Google Scholar
• . Johansson G, Lindberg A, Romberg K, Nordstrom L, Gerken F, Roquet A. Bronchodilator efficacy of tiotropium in patients with mild to moderate COPD. Prim Care Respir J. 2008;17(3):169–175
   PubMedGoogle Scholar
• . Rutten-van Molken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest. 2006;130(4):1117–1128
   PubMed Web of Science ®Google Scholar
• . O'Donnell DE, Fluge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, . Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004;23(6):832–840
   PubMed Web of Science ®Google Scholar
• . Maltais F, Hamilton A, Marciniuk D, Hernandez P, Sciurba FC, Richter K, . Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest. 2005;128(3):1168–1178
   PubMed Web of Science ®Google Scholar
• . Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005;127(3):809–817
   PubMed Web of Science ®Google Scholar
• . O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD. Thorax. 2009;64(3):216–223
   PubMed Web of Science ®Google Scholar